Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1

NCT06517693 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

NIH

Sponsor class

Conditions

HIV-1

Interventions

DRUG: PGT121.414.LS
DRUG: VRC07-523LS

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]